Our Clinical Genomics Center is an expert center in molecular medicine for rare diseases and tumors, advancing precision medicine through genetic testing. Since 2021, the Republic Health Insurance Fund of Serbia (RFZO) has been supporting genetic testing for patients with suspected rare diseases through advanced diagnostic methods, including next generation sequencing (NGS) and detection of sequence and structure variants of genes and whole chromosomes. This approach enables the simultaneous analysis of 4,813 clinically relevant genes (CES) or entire set of human genes (around 20,000 genes) (WES), providing comprehensive genetic insights and more accurate diagnoses.

Within this center of excellence, a specialized Center for Genetic Diagnostics of Rare Diseases has been established, dedicated exclusively to rare disease diagnostics and performing more than 3,500 genetic analyses annually.